J9150 Daunorubicin injection
Also known as: daunorubicin, Cerubidine, daunomycin
Intravenous injection of daunorubicin, an anthracycline topoisomerase II inhibitor chemotherapy agent.
In Plain Language
red chemotherapy drug; DNA-damaging cancer drug
Clinical Context
Used for acute leukemias, particularly acute myeloid leukemia and acute lymphoblastic leukemia.
RVU Information
CPT J9150 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9150?
CPT J9150 (Daunorubicin injection) is a J Codes (Drugs) code. Intravenous injection of daunorubicin, an anthracycline topoisomerase II inhibitor chemotherapy agent.
How is J9150 administered?
CPT J9150 is administered by a healthcare provider, typically via injection or infusion. Used for acute leukemias, particularly acute myeloid leukemia and acute lymphoblastic leukemia. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9150 used?
Used for acute leukemias, particularly acute myeloid leukemia and acute lymphoblastic leukemia.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.